関連する実験動画
Updated: Aug 11, 2026

12:19
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
MDM2オンコタンパク質によるE2F1/DP1の転写活性の刺激
K Martin1, D Trouche, C Hagemeier
1Wellcome/CRC Institute, Cambridge, UK.
Nature
|June 22, 1995
まとめ
MDM2腫瘍遺伝子は,p53腫瘍抑制剤を抑制することによって癌を促進します. この研究では,MDM2がE2F1/DP1を刺激するとともに,腫瘍の細胞増殖を促進することが明らかになりました.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 細胞サイクル規制について
背景:
- MDM2増幅は,様々な腫瘍で一般的です.
- MDM2の腫瘍性作用は,p53抑制と関連しています.
- E2F1とDP1は,S相進行の重要な転写因子である.
研究 の 目的:
- MDM2とE2F1/DP1.1の相互作用を調査する.
- E2F1/DP1活動に対するMDM2の影響を決定する.
主な方法:
- タンパク質とタンパク質の相互作用を研究するための生化学分析.
- 転写活性を評価するための機能検査.
主要な成果:
- MDM2は,E2F1のアクティベーションドメインに直接連絡します.
- E2F1/DP1へのMDM2結合は,それらの転写活動を強化する.
- この刺激は,p53.5に対するMDM2の抑制効果と対照的です.
結論:
- MDM2は,p53を抑制し,E2F1/DP1.1を刺激することで,腫瘍の成長を促進する.
- MDM2は,転写因子調節を通じて細胞増殖を活発に増加させます.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

